Induction of the antitumor response in primary tumors did not require CD4+ T cell populations in B16 melanoma [15] or disseminated pancreatic tumors [19], although in treated mice that survived the primary cancer, CD4+ T cells were shown to play an important role in enforcing immunity to pancreatic cancer [20]. Here, CD4 is linked to familial pancreatic carcinoma.